Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Viva Biotech has optimized its Proteina-Complexa model using NVIDIA technology to accelerate AI-driven drug discovery, focusing on designing mini-binders targeting the ActRIIA receptor linked to muscle wasting.
Latham & Watkins has announced that Jennifer Yoo has rejoined its Los Angeles office as a partner in the Healthcare & Life Sciences Practice, focusing on digital health, AI-enabled healthcare solutions, and regulatory compliance.
IntelePeer has achieved TX-RAMP Level 2 certification, confirming its compliance with Texas state security standards for cloud-based AI communication systems used in regulated sectors such as healthcare and government.
OPTEL Group and Kaster Technologies have announced a partnership to deliver an AI-powered production planning solution for pharmaceutical manufacturers, combining real-time traceability data with intelligent scheduling to improve efficiency and capacity.
EnrollHere has introduced EnrollHere Complete, an AI-powered platform that unifies behavioral intelligence, compliance oversight, and financial infrastructure to improve transparency and protect Medicare beneficiaries.
Persistent Systems has announced a collaboration with NVIDIA to develop AI-powered solutions for computational drug discovery, using NVIDIA’s BioNeMo and NeMo Agent Toolkit to create generative molecular simulations and agentic workflows.
PerturbAI has launched from stealth, unveiling an 8-million-cell in vivo CRISPR atlas developed with NVIDIA, the Allen Institute for Brain Science, and 10x Genomics, marking the largest causal genomics dataset generated in living tissue.
Percipio Health has joined the American Heart Association’s Center for Health Technology & Innovation’s Innovators’ Network to collaborate on AI-driven cardiovascular care solutions.
Maven Clinic has introduced Maven Intelligence, an AI-powered orchestration layer designed to deliver more connected and personalized care across fertility, maternity, parenting, and menopause programs.
Sequential has raised $3.5 million in its first equity round to develop an AI-powered discovery engine for next-generation skin health ingredients. The funding was co-led by Sparkfood and Corundum Systems Biology, with participation from several investors.
Ethermed and VisiQuate have announced a strategic partnership to integrate AI-driven automation and predictive modeling for faster prior authorizations and improved revenue cycle performance in healthcare organizations.
Sectra has agreed to acquire Lithuanian radiology AI company Oxipit, known for its CE Class IIb-certified autonomous chest X-ray solution, ChestLink. The deal is expected to close in March 2026 and will see Oxipit operate as Sectra’s dedicated AI development center.
Nao Medical has partnered with Flexzo Ai to accelerate clinician hiring and workforce deployment across its expanding network of primary, urgent, and mental health care clinics. The collaboration leverages AI-driven automation to predict staffing needs and improve recruitment efficiency.
Vitestro has closed a $70 million Series B funding round to support development and commercialization of its Aletta Autonomous Robotic Phlebotomy Device, with participation from Labcorp Venture Fund, Mayo Clinic, and Sutter Health.
Bota has introduced SAION AI, described as the first Physical AI platform for biomanufacturing. The system integrates cognition, orchestration, and execution layers to automate and optimize biological research and production.
Andor Health announced an expansion of its Rural Health Transformation program through the integration of its ThinkAndor AI platform with PsynergyHealth’s virtual clinical workforce, aiming to improve access and efficiency for rural healthcare providers.
Waystar has expanded its collaboration with Google Cloud to integrate Gemini models and data infrastructure into its AltitudeAI platform, aiming to advance agentic AI capabilities and enable a self-learning healthcare revenue cycle.
Mosaic Clinical Technologies has received FDA Breakthrough Device Designation for Cognita CXR, a generative AI model designed to assist radiologists in interpreting chest X-rays. The designation allows prioritized interaction with the agency as the company advances toward clearance.
MDClone has introduced ADAMS Copilot, a generative AI-powered assistant designed to help healthcare teams analyze and act on complex data securely within their own systems.
Certilytics has launched CertHLM, an AI-powered interface that provides healthcare organizations with real-time expert-level insights from their own data. The platform will debut at HIMSS 2026 in Las Vegas.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
